Evidence map›Paper›PMID 31527084›Full record

ArticleThe Journal of biological chemistry2019

Phosphorylation of the multifunctional signal transducer B-cell adaptor protein (BCAP) promotes recruitment of multiple SH2/SH3 proteins including GRB2.

Johannes U Lauenstein, Atul Udgata, Alex Bartram, Delphine De Sutter, David I Fisher, Samer Halabi, Sven Eyckerman, Nicholas J Gay

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Johannes U LauensteinDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.
Atul UdgataDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.
Alex BartramDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.
Delphine De SutterDepartment of Biomolecular Medicine, Ghent University, VIB Center for Medical Biotechnology, VIB, A. Baertsoenkaai 3, Ghent B-9000, Belgium.
David I FisherDiscovery Sciences, Discovery Biology, IMED Biotech Unit, AstraZeneca, Cambridge CB4 0WG, United Kingdom.
Samer HalabiDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.
Sven EyckermanDepartment of Biomolecular Medicine, Ghent University, VIB Center for Medical Biotechnology, VIB, A. Baertsoenkaai 3, Ghent B-9000, Belgium.
Nicholas J GayDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom njg11@cam.ac.uk.ORCID 0000-0002-2782-7169
University of Cambridge · GBGhent University · BEAstraZeneca (United Kingdom) · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

B-cell adaptor protein (BCAP) is a multimodular, multifunctional signal transducer that regulates signal transduction pathways in leukocytes, including macrophages, B-cells, and T-cells. In particular, BCAP suppresses inflammatory signaling by Toll-like receptors (TLRs). However, how BCAP itself is regulated and what its interaction partners are is unclear. Here, using human immune cell lines, including THP-1 cells, we characterized the complex phosphorylation patterns of BCAP and used a novel protein complex trapping strategy, called virotrap, to identify its interaction partners. This analysis identified known interactions of BCAP with phosphoinositide 3-kinase (PI3K) p85 subunit and NCK adaptor protein (NCK), together with previously unknown interactions of BCAP with Src homology 2 (SH2) and SH3 domain-containing adaptor proteins, notably growth factor receptor-bound protein 2 (GRB2) and CRK-like proto-oncogene, adaptor protein (CRKL). We show that the SH3 domain of GRB2 can bind to BCAP independently of BCAP phosphorylation status, suggesting that the SH2 domains mediate interactions with activated receptor tyrosine kinase complexes including the CD19 subunit of the B-cell receptor. Our results also suggested that the PI3K p85 subunit binds to BCAP via SH3 domains forming an inactive complex that is then activated by sequential binding with the SH2 domains. Taken together, our results indicate that BCAP is a complex hub that processes signals from multiple pathways in diverse cell types of the immune system.

Indexed as

Adaptor Proteins, Signal TransducingAgammaglobulinaemia Tyrosine KinaseAmino Acid MotifsBinding SitesCell Line, TumorGenes, ReporterGRB2 Adaptor ProteinHEK293 CellsHumansMass SpectrometryOncogene ProteinsPeptidesPhosphatidylinositol 3-KinasesPhosphorylationProtein BindingProto-Oncogene MasAdaptor Proteins, Signal TransducingAgammaglobulinaemia Tyrosine KinaseBTK protein, humanCRKL proteinGRB2 Adaptor ProteinGRB2 protein, humanMAS1 protein, humanNck proteinOncogene ProteinsPeptidesPhosphatidylinositol 3-Kinasesphosphoinositol-3 kinase regulatory subunit 2, humanPIK3AP1 protein, humanProto-Oncogene MasB-cell adaptor proteinimmunitykinase signalingphosphoinositide 3-kinasephosphorylationsignal transductionSrc homology 2 domain (SH2 domain)Src homology 3 domain (SH3 domain)Toll-like receptor (TLR)virotrap

Identifiers

PMID31527084
PMCPMC6937578
OpenAlexW2974218482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.